Expediting A Promising New Therapy With RP Scherer Softgel Technology
RP Scherer Softgel Case Study: Expediting a Promising New Therapy with RP Scherer Softgel Technology
Author: Catalent Pharma Solutions
Summary: An innovative biotechnology company exploring novel therapeutics for neuroscience indications had developed a promising new chemical entity for the treatment of a severe pediatric genetic disease. However, numerous drug delivery challenges threatened the realization of the Fast Track status designation they had received due to promising early stage results. By partnering with Catalent and leveraging our proprietary RP Scherer Softgel technology, the customer was able to overcome a number of potential hurdles and expeditiuosly enter the Phase II/III clinical trial.